Dalton Pharma Services has expanded its cGMP sterile powder filling capabilities with the addition of a high-speed automated sterile powder filling line to fill large commercial batches of vials. The new cGMP equipment will be installed in a dedicated suite with local Class A environment and isolator style containment.
 
The company is also adding intermediate scale cGMP sterile powder filling equipment to produce small to medium sized clinical trial batches. This mid-scale equipment will also be operated under a Class A environment and containment system. The new sterile manufacturing capacity is semi-automated and provides 100% check weighing for batches up to 10,000 vials, according to the company.
   
“The strategic decision to invest in specialized sterile powder filling was driven primarily by the demand in this market globally and by our existing customers,” said Peter Pekos, chief executive officer and president, Dalton Pharma Services. “The significant investments we are making in these sterile manufacturing and development capabilities allow Dalton to maintain its leadership position in sterile powder manufacturing, and accelerate the application of these innovations to the leading-edge commercial pharmaceutical products of our customers.”